Otarmeni™ (lunsotogene parvec-cwha) Approved by FDA as First and Only Gene Therapy for Genetic Hearing Loss; Regeneron to Provide Otarmeni for Free in the U.S.

Approval in severe-to-profound and profound OTOF -related hearing loss is based on pivotal results of the CHORD trial demonstrating 80% of ...
list25 on MSN

100 jaw-dropping facts you never learned in school

Discover 100 Jaw Dropping Facts You Never Learned in School! Uncover bizarre history, science secrets, and mind-blowing ...